Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.42)
# 906
Out of 4,843 analysts
81
Total ratings
34.18%
Success rate
8.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRTA Prothena Corporation | Maintains: Overweight | $110 → $81 | $4.59 | +1,664.71% | 3 | May 27, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $73.35 | +97.68% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $14.28 | +257.14% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $0.63 | +857.55% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $4.00 | +1,100.00% | 1 | Feb 28, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $25.95 | +258.38% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $9.23 | +712.57% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $0.72 | +866.18% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $6.46 | +302.48% | 2 | Oct 30, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $18.11 | +104.31% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $1.01 | +2,474.26% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.66 | +4,143.07% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $30.51 | +217.93% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $38.55 | +600.39% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $21.53 | +253.08% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $5.43 | +360.41% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $15.26 | +96.59% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $3.76 | +219.15% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $81.20 | -55.67% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.59 | +1,436.36% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $11.49 | +1,467.26% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $1.11 | +1,251.35% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $275.26 | +22.07% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.28 | +601.75% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $22.23 | +259.87% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $21.76 | +327.39% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $16.68 | +289.69% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $14.85 | +283.84% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $3.55 | +1,787.32% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $47.47 | -26.27% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $5.91 | +1,373.33% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $5.29 | +3,208.13% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $31.02 | +132.11% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $1.35 | +1,900.00% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $9.84 | +93.09% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $1.70 | +2,841.18% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.46 | +8,595.65% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.43 | +4,056.08% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $11.69 | +3,492.81% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $12.53 | +514.53% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $44.42 | +73.35% | 1 | Jul 31, 2020 |
Prothena Corporation
May 27, 2025
Maintains: Overweight
Price Target: $110 → $81
Current: $4.59
Upside: +1,664.71%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $73.35
Upside: +97.68%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $14.28
Upside: +257.14%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $0.63
Upside: +857.55%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $4.00
Upside: +1,100.00%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $25.95
Upside: +258.38%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $9.23
Upside: +712.57%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $0.72
Upside: +866.18%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $6.46
Upside: +302.48%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $18.11
Upside: +104.31%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.01
Upside: +2,474.26%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.66
Upside: +4,143.07%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $30.51
Upside: +217.93%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $38.55
Upside: +600.39%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $21.53
Upside: +253.08%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $5.43
Upside: +360.41%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $15.26
Upside: +96.59%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $3.76
Upside: +219.15%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $81.20
Upside: -55.67%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.59
Upside: +1,436.36%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $11.49
Upside: +1,467.26%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.11
Upside: +1,251.35%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $275.26
Upside: +22.07%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.28
Upside: +601.75%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $22.23
Upside: +259.87%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $21.76
Upside: +327.39%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $16.68
Upside: +289.69%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $14.85
Upside: +283.84%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $3.55
Upside: +1,787.32%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $47.47
Upside: -26.27%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $5.91
Upside: +1,373.33%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $5.29
Upside: +3,208.13%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $31.02
Upside: +132.11%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $1.35
Upside: +1,900.00%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $9.84
Upside: +93.09%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $1.70
Upside: +2,841.18%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.46
Upside: +8,595.65%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.43
Upside: +4,056.08%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $11.69
Upside: +3,492.81%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $12.53
Upside: +514.53%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $44.42
Upside: +73.35%